United States v. Rivera-Rodriguez

75 F.4th 1
Court of Appeals for the First Circuit·Decided July 20, 2023·No. 21-1137·Published·Cited by 11 cases

Opinion

United States Court of Appeals For the First Circuit

No. 21-1137 UNITED STATES,

Appellant,

v.

MARIO R. RIVERA-RODRÍGUEZ, a/k/a Papolín, Defendant, Appellee.

APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF PUERTO RICO

[Hon. Jay A. García-Gregory, U.S. District Judge]

Before

Gelpí, Howard, and Thompson, Circuit Judges.

David C. Bornstein, Assistant United States Attorney, with whom W. Stephen Muldrow, United States Attorney, and Mariana E. Bauzá-Almonte, Assistant United States Attorney, were on brief for appellant.

Samuel Carrion, with whom Eric Alexander Vos, Federal Public Defender, Franco L. Pérez-Redondo, Assistant Federal Public Defender, and Kevin E. Lerman, Research & Writing Attorney, were on brief for appellee.

July 20, 2023

THOMPSON, Circuit Judge. Today's appeal confronts both the extraordinary and the, arguably, mundane. The government seeks reversal of two district court rulings, one granting appellee, Mario Rivera-Rodríguez ("Rivera"), compassionate release from incarceration, the other denying the government's subsequent request for reconsideration. We face the extraordinary as we contemplate whether the district court below was obligated to rescind the compassionate release it had granted to Rivera premised upon his heightened health risks associated with the COVID-19 virus (COVID) (in and of itself, an extraordinary remedy). And we face the mundane as we consider whether it was reasonable for the court to conclude, in the exercise of its considerable discretion, that although Rivera had in fact been vaccinated before his release, reconsideration of its initial judgment was not warranted here.

For reasons we get into below, we affirm. We begin by describing the events leading up to, and following, the district court's release grant before zooming out to provide broader context on compassionate release and the government's authority to appeal its grant. We conclude by exploring the merits of the government's challenges to both judgments below -- arguments we ultimately reject.

I. Background

A. Rivera's Crime & Sentencing On August 6, 2009, Saro Díaz-Rosa lost his life at the hands of Rivera and another person (an unidentified "John Doe"). Rivera and an accomplice, arriving at a gas station in Río Grande, Puerto Rico, spotted Díaz-Rosa standing at an air pump. After sizing him up and making the decision to steal his Ford Club Wagon, they proceeded to shoot at Díaz-Rosa multiple times, ultimately killing him. Hightailing the vehicle away from the station, Rivera and his compadre wound up abandoning it later in the day on Calle Yunquecito in Carolina.

While to this day his accomplice remains unidentified, Rivera surrendered and was arrested by authorities the following month. In October 2009, he was indicted for carjacking resulting in death in violation of 18 U.S.C. § 2119(3) and discharging a firearm causing the murder of a person in violation of 18 U.S.C. § 924(c)(1)(A)(iii), (j).

Eventually, Rivera accepted a plea agreement, under which he pled guilty to the carjacking count in exchange for the government's agreement to drop the firearms charge and recommend

he serve a 240-month prison sentence.1 The agreement was reviewed by the court during Rivera's November 2011 sentencing hearing.2 Pursuant to its sentencing tasks, the court, after determining the applicable guideline sentencing range to be from 210 to 262 months, accepted the government's recommendation under the agreement -- imposing a term of 240 months of incarceration, followed by five years of supervised release.

B. COVID & Compassionate Release Nearly nine years later, along comes COVID. On January 31, 2020, federal authorities declared the highly transmissible virus to be a public health emergency. See Proclamation No. 9994, 85 Fed. Reg. 15337 (Mar. 13, 2020). As the

1 Under the terms of the agreement, he also agreed to withdraw a motion he had filed seeking to suppress his confession, which he had given after waiving his Miranda rights. See Miranda v. Arizona, 384 U.S. 436, 475 (1966) ("If [an] interrogation continues without the presence of an attorney and a statement is taken, a heavy burden rests on the government to demonstrate that the defendant knowingly and intelligently waived his privilege against self-incrimination and his right to retained or appointed counsel.").

2 During the hearing the court acknowledged several mitigating sentencing factors raised by the defense such as Rivera's various familial traumas, including his troubled childhood. The same went for Rivera's issues with addiction and his mental, cognitive, and emotional deficiencies. At one point, the court raised Rivera's probable "frontal lobe structural deficiencies . . . which [affect] the ability to understand the consequences of certain actions." The hearing also included testimony from Díaz-Rosa's family expressing the significant devastation and struggles they faced since his death, and from Rivera expressing his deep remorse for the crime he had committed.

pandemic presented health risks to vulnerable communities throughout the globe, our public health authorities concluded that the risk of infection was particularly acute among those housed in densely occupied congregate settings such as prisons. See Centers for Disease Control and Prevention, Guidance on Management of COVID-19 in Homeless Service Sites and in Correctional and Detention Facilities (Mar. 23, 2020), https://www.cdc.gov/corona virus/2019-ncov/community/correction-detention/guidance- correctional-detention.html.

That October, represented by the public defender, Rivera, who his prison FCI Butner I ("Butner") had classified as a chronic care inmate, identified himself as uniquely at risk of death or severe illness were he to contract COVID, due to his obesity, chronic hypertension, and pre-diabetes. Accordingly, he motioned the court for compassionate release under the First Step Act, 18 U.S.C. § 3582(c)(1)(A), which authorizes the federal courts to reduce an incarcerated individual's prison term should there be "extraordinary and compelling" reasons for doing so.3 In his written submission, he argued that his heightened health risks

318 U.S.C. § 3582(c)(1)(A)(i) states that a court "may reduce the term of imprisonment (and may impose a term of probation or supervised release with or without conditions that does not exceed the unserved portion of the original term of imprisonment), after considering the [sentencing] factors set forth in section 3553(a) to the extent that they are applicable, if it finds that extraordinary and compelling reasons warrant such a reduction . . . ."

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Rivera-Rodriguez, 75 F.4th 1 (1st Cir. 2023).

75 F.4th 1 (United States v. Rivera-Rodriguez) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Untitled Case
M.D. Georgia, 2026
United States v. Burgos-Montes
142 F.4th 48 (First Circuit, 2025)
United States v. Vinas
106 F.4th 147 (First Circuit, 2024)
United States v. Abreu
106 F.4th 1 (First Circuit, 2024)
United States of America v. Stephen G. Burke
2024 DNH 025 (D. New Hampshire, 2024)
Castro v. NH Secretary of State
D. New Hampshire, 2023
United States v. Quiros-Morales
83 F.4th 79 (First Circuit, 2023)